about
The calcium phosphate matrix of FGF-2-apatite composite layers contributes to their biological effects.BMP-2 gene-fibronectin-apatite composite layer enhances bone formationArea-specific cell stimulation via surface-mediated gene transfer using apatite-based composite layersImprovement in endothelial cell adhesion and retention under physiological shear stress using a laminin-apatite composite layer on titanium.Zn- and Mg- containing tricalcium phosphates-based adjuvants for cancer immunotherapy.Solubility of Mg-containing beta-tricalcium phosphate at 25 degrees CFormation of apatite coatings on an artificial ligament using a plasma- and precursor-assisted biomimetic process.A phase I study on combined therapy with proton-beam radiotherapy and in situ tumor vaccination for locally advanced recurrent hepatocellular carcinoma.Tissue-engineered endothelial cell layers on surface-modified Ti for inhibiting in vitro platelet adhesion.Fabrication of DNA-antibody-apatite composite layers for cell-targeted gene transfer.Development of an early estimation method for predicting later osteogenic differentiation activity of rat mesenchymal stromal cells from their attachment areas.Improved bonding of partially osteomyelitic bone to titanium pins owing to biomimetic coating of apatite.Reducing the risk of impaired bone apposition to titanium screws with the use of fibroblast growth factor-2-apatite composite layer coating.Hollow boron nitride nanospheres as boron reservoir for prostate cancer treatment.Signal molecules-calcium phosphate coprecipitation and its biomedical application as a functional coating.Calcium phosphate composite layers for surface-mediated gene transfer.Interlaboratory studies on in vitro test methods for estimating in vivo resorption of calcium phosphate ceramics.Particle-size-dependent toxicity and immunogenic activity of mesoporous silica-based adjuvants for tumor immunotherapy.Mesoporous silica-calcium phosphate-tuberculin purified protein derivative composites as an effective adjuvant for cancer immunotherapy.Reduction of surface roughness of a laminin-apatite composite coating via inhibitory effect of magnesium ions on apatite crystal growth.In vitro/ in vivo evaluation of the efficacy of gatifloxacine-loaded PLGA and hydroxyapatite composite for treating osteomyelitis.Laminin-apatite composite coating to enhance cell adhesion to ethylene-vinyl alcohol copolymer.Effects of gatifloxaine content in gatifloxacine-loaded PLGA and β-tricalcium phosphate composites on efficacy in treating osteomyelitis.Ascorbate-apatite composite and ascorbate-FGF-2-apatite composite layers formed on external fixation rods and their effects on cell activity in vitro.Silicate-apatite composite layers on external fixation rods and in vitro evaluation using fibroblast and osteoblast.Enhanced wound healing associated with Sharpey's fiber-like tissue formation around FGF-2-apatite composite layers on percutaneous titanium screws in rabbits.The most appropriate (Ca+Zn)/P molar ratio to minimize the zinc content of ZnTCP/HAP ceramic used in the promotion of bone formation.Formation of a FGF-2 and calcium phosphate composite layer on a hydroxyapatite ceramic for promoting bone formation.Pore size-dependent immunogenic activity of mesoporous silica-based adjuvants in cancer immunotherapy.DNA-lipid-apatite composite layers enhance gene expression of mesenchymal stem cells.Formation and growth of clusters in conventional and new kinds of simulated body fluids.Biomimetic coating of an apatite layer on poly(L-lactic acid); improvement of adhesive strength of the coating.Novel gene-transferring scaffolds having a cell adhesion molecule-DNA-apatite nanocomposite surface.Fibronectin-DNA-apatite composite layer for highly efficient and area-specific gene transfer.Effect of geometrical structure on the biodegradation of a three-dimensionally perforated porous apatite/collagen composite bone cell scaffold.Controlled superficial assembly of DNA-amorphous calcium phosphate nanocomposite spheres for surface-mediated gene delivery.Formation of an ascorbate-apatite composite layer on titanium.Hierarchically porous, and Cu- and Zn-containing γ-AlOOH mesostrands as adjuvants for cancer immunotherapy.Synergistic effects of stellated fibrous mesoporous silica and synthetic dsRNA analogues for cancer immunotherapy.Stimulation of In Vivo Antitumor Immunity with Hollow Mesoporous Silica Nanospheres.
P50
Q33907735-F2F7B10B-4E32-4D8B-9284-9AB1278985C0Q35219496-589DFEF2-5D23-4FC2-BB3A-E458F14CC6B6Q35585655-FE498C0E-20F2-4D7A-866B-E3EBF657E969Q36767994-DBE1AA91-BCBD-457D-AF01-1DDB65076622Q37015757-C710577F-2405-4B0E-8F1A-7073C07F65A5Q37072964-1B408499-0C10-44B0-BAF7-516C15AE63E3Q37225278-5CFEDCB4-8396-4A24-9714-B6B167237C30Q37371686-124A8F4D-54B3-4D3B-8A74-B477C179D985Q37386687-38464499-9080-40C4-9578-6C28CBF8AD17Q37399921-ED3D08CB-1833-497C-98B9-6F8D1DF006F7Q37399936-65AB1867-0D47-4292-AA9B-8D491673B88DQ37421011-09AD7B7B-B473-4296-AA52-4AA6D1F5DA9BQ37566077-B7A46F30-D6A2-4570-9CEC-C5A339D50F49Q37582113-9D6EA0F0-1A50-4C37-9471-21D1AF4AE82AQ37862921-B68264AB-EA86-40DD-A277-D3389D796341Q37985501-2C6FA17F-9662-4C45-BF90-E977D2DA22B9Q38978805-27521E9D-EA68-402A-8DF9-92057E807942Q39173654-9B5B77F6-276B-4DD4-84E2-BB15705111B0Q39214943-B1BCE417-4F3B-41FD-A662-763E373FF1D5Q39981291-A08327B1-3982-4027-AD1C-B42CB4E4D316Q40167950-DEB48F38-EE30-475D-9181-AC7CAE31F9CAQ40485072-C77C352C-4918-4B5B-A8DD-439632FD10A6Q41586328-8D793F89-2F7B-42EE-B92A-34EB43A60C6DQ42800814-F5092433-9C85-440D-87B6-D66C3C99FB20Q42801692-B146BE25-5FBD-49B1-8D6F-5143AB0F31F8Q42805860-84F43183-1886-4F9B-8AC1-E992C48F6E89Q42810830-9DD10C12-F6A8-4AF3-B43E-48A0DD64244EQ42813508-D4549E27-6E70-4CBB-B606-4D0654A8365BQ42819836-9D551C57-EF18-49CD-B44F-DC1DD2CAF07AQ42827403-8976CEFE-531E-42A3-ACF1-40CB2B60C3DFQ44274952-EC8D89C8-FF63-48C0-8185-315E76FC0E13Q45374229-B45C3372-406F-40F9-A71A-A5A0B1B90FD6Q45872012-93219D28-3240-42EB-A999-78B9BED67703Q45883889-BA199075-F78E-4467-B65A-16E1D4A02396Q46112367-D5BD6A5F-6C5A-4068-AED0-B26B04A93EE6Q46278647-48EEB7FA-BDF2-43DC-8293-895940BA8CA8Q46610715-78D33462-3EA1-45D0-8DC3-6770F76A6DDBQ47174541-71D57209-1A2A-4C8D-86FF-C5B3F4343F1CQ47738760-31F8E971-9B6B-4478-A479-3596ACFE18B5Q48128797-4626BA84-419E-4747-BF96-A5E51AFA103E
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Atsuo Ito
@ast
Atsuo Ito
@en
Atsuo Ito
@es
Atsuo Ito
@nl
type
label
Atsuo Ito
@ast
Atsuo Ito
@en
Atsuo Ito
@es
Atsuo Ito
@nl
prefLabel
Atsuo Ito
@ast
Atsuo Ito
@en
Atsuo Ito
@es
Atsuo Ito
@nl
P106
P31
P496
0000-0003-3318-040X